Virology
EMA lifts temporary ban on chikungunya vaccine Ixchiq following safety review
July 18, 2025Medical Communications Committee for Medicinal Products for Human USE, European Medicines Agency (EMA), Ixchiq, Pharmacovigilance Risk Assessment Committee (PRAC), Vaccine, Virology, chikungunya
After completing a safety review of Ixchiq – a vaccine for chikungunya – the European Medicines Agency’s (EMA) safety committee …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
July 16, 2025Medical Communications COVID-19, Spikevax, US Food and Drug Administration, Vaccine, Virology
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, Spikevax, in children aged six …
Osivax publishes positive results from trial of influenza vaccine candidate
July 15, 2025Research and Development Osivax, Vaccine, Virology, clinical trial, influenza, respiratory diseases
French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead …
Oxeltis secures €800,000 grant to advance antiviral candidate for emerging tropical viruses
June 26, 2025Medical Communications, Research and Development Corporate, Defense Innovation Agency, National Research Agency, Oxeltis, RNA viruses, Virology, contract research organisation
Oxeltis, a French contract research organisation specialising in medicinal and organic chemistry, has announced that it will lead the BUNYANTIVIR …
Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine
June 6, 2025Research and Development Ghent University Hospital, Osivax, Vaccine, Virology, clinical trial, influenza a
Osivax has announced the completion of patient visits in its phase 2a trial evaluating a booster dose of OVX836, a …
Study links COVID-19 and some vaccines to increased risk of rare neurological condition
June 5, 2025Medical Communications, Medical Education, Medical/ Scientific Writing, Research and Development COVID-19, COVID-19 vaccine, Guillain-Barré Syndrome (GBS), Neurology, Virology, adenoviral vector vaccines, mRNA-based vaccines, medical study, neurological condition
An international study has found an increased risk of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and after vaccination with adenoviral …
Moderna authorised to upscale development of mRNA vaccines in UK
April 15, 2025Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination
Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …
FDA accepts Atara Biotherapeutics’ Tab-Cel for priority review
July 18, 2024Medical Communications Atara Biotherapeutics, FDA, Virology, priority review
Atara Biotherapeutics has announced that the US Food and Drug Administration (FDA) has accepted the filing of its Biologics License …
NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis
May 15, 2023Medical Communications NHS, NICE, Virology, hepatitis
The National Institute for Health and Care Excellence (NICE) has recommended Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta …
CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates
May 9, 2023Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines
CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …
FDA approves world’s first RSV vaccine
May 4, 2023Medical Communications FDA, RSV, Vaccine, Virology
The US Food and Drug Administration (FDA) has announced that it has approved the world’s first respiratory syncytial virus (RSV) …
